| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.42B | +15.4% |
| Cost of Revenue | $514.9M | +6.4% |
| R&D Expense | $746.8M | +15.0% |
| SG&A Expense | $937.3M | +9.8% |
| Operating Income | $158.1M | +5.7% |
| Interest Expense | $17.3M | +8.5% |
| Pre-tax Income | $188.6M | +26.1% |
| Income Tax | $20.9M | +161.0% |
| Net Income | $167.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $755.1M | +4.2% |
| Accounts Receivable | $633.7M | +37.4% |
| Inventory | $1.11B | +23.8% |
| Current Assets | $2.96B | +7.4% |
| Total Assets | $6.84B | +7.3% |
| Current Liabilities | $1.18B | +99.9% |
| Total Liabilities | $1.89B | +6.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $159.3M | -9.5% |
| Capital Expenditures | $96.7M | -20.1% |
| Investing Cash Flow | -$111.2M | -455.4% |
| Financing Cash Flow | -$18.7M | -0.4% |
| Free Cash Flow | $62.6M | +13.9% |
| +18.4% |
| EPS (Basic) | $0.89 | +17.1% |
| EPS (Diluted) | $0.87 | +16.0% |
| Stockholders' Equity |
| $4.95B |
| +7.6% |